R. Bachman

发表

A5814G Mutation in Mitochondrial DNA Can Cause Mitochondrial Myopathy and Cardiomyopathy

S. Dimauro, C. Sue, R. Bachman, 2001, Journal of child neurology.

Phase 1 study of pembrolizumab (pembro; MK-3475) plus ipilimumab (IPI) as second-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 cohort D.

M. Socinski, A. Patnaik, S. Gadgeel, 2015 .

Pembrolizumab (pembro; MK-3475) plus platinum doublet chemotherapy (PDC) as front-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 Cohorts A and C.

L. Sequist, H. Borghaei, A. Patnaik, 2015 .

Long‐Term Open‐Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs

C. Lines, K. Connor, T. Ho, 2013, Headache.

Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design

L. Mozley, C. Lines, K. Connor, 2012, Cephalalgia : an international journal of headache.

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

C. Lines, D. Dodick, S. Aurora, 2011, Cephalalgia : an international journal of headache.

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

L. Sequist, H. Borghaei, A. Patnaik, 2018, Lung cancer.

Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy

R. Kuzniecky, R. Knowlton, H. Pardoe, 2015, Epilepsy & Behavior.

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

R. Lipton, D. Dodick, S. Aurora, 2016, Cephalalgia : an international journal of headache.

Pembrolizumab (pembro) plus chemotherapy as front-line therapy for advanced NSCLC: KEYNOTE-021 cohorts A-C.

L. Sequist, H. Borghaei, A. Patnaik, 2016 .